| MDL | - |
|---|---|
| Molecular Weight | 163.18 |
| Molecular Formula | C4H13N5O2 |
| SMILES | O=NN(O)N(CCN)CCN |
DETA NONOate (100 μM; 16 h) induces growth in an Mycobacterium abscessus complex (MABC) R morphotype by reduced glycopeptidolipid (GPL) expression of M. abscessus subspecies abscessus (Mab) [3] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
DETA NONOate (15-150 μg/rat, i.c.v., once) exhibits a nociceptive effect in the rat formalin model
[2]
.
DETA NONOate (1 µM) reduces ischemia- or ischemia/reperfusion-induced injury to cardiac mitochondria and prevents apoptotic cell death
[4]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| Animal Model: | Sprague-Dawley rats (Sixty-two, male, 200-250 g) [2] |
| Dosage: | 15 or 150 μg per rat |
| Administration: | i.c.v., once |
| Result: | Accelerated the nociception in a dose-dependent manner, and this acceleration was completely abolished by Methylene Blue (HY-14536). |
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
H 2 O : 50 mg/mL ( 306.41 mM ; ultrasonic and adjust pH to 9 with H 2 O)
DMSO : < 1 mg/mL (ultrasonic) (insoluble or slightly soluble)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 6.1282 mL | 30.6410 mL | 61.2820 mL |
| 5 mM | 1.2256 mL | 6.1282 mL | 12.2564 mL |
| 10 mM | 0.6128 mL | 3.0641 mL | 6.1282 mL |